Medical Breakthroughs Reported by Ivanhoe.com. Click here to go to the homepage.
Be the First to Know. Click here to subscribe FREE!
Search Reports: Use quotation marks around your multi-word search terms in the box below to perform search of Ivanhoe.com.
Advances in health and medicine.Use " marks around search terms
 
What's New
News Flash
Discussion
healthchannelnews
  Alternative Health
Arthritis
Asthma & Allergies
Autism
Breast Cancer
Cancer
Cardiovascular Health
Children's Health
Dental Health
Diabetes
Fertility & Pregnancy
Men's Health
Mental Health
Multiple Sclerosis
Neurological Disorders
Nutrition & Wellness
Orthopedics
Pet Health
Robotics
Seniors' Health
Sports Medicine
Vision
Women's Health
Advances in health and medicine.
Click here to sign up for Medical Alerts!
Click below to access other news from Ivanhoe Broadcast News.
  Click here to get Ivanhoe's Medical Headline RSS feed Click here to listen to Ivanhoe's Medical Podcasts
Useful Links
Play It Again, Please
E-Mail a Friend
Order Books Online
Inside Science
Smart Woman
Advances in health and medicine.
Smart Woman Home
Click here to read the story
Click here to read the story
Click here to read the story
Smart Woman Home
Advances in health and medicine.
Click below to learn about Ivanhoe.
  Awards
About Us
Contact Us
Employment
Feedback
Ivanhoe FAQ
Our TV Partners
Travel Calendar
Advances in health and medicine.
Ivanhoe celebrates 20 years of medical news reporting reaching nearly 80 million TV households each week. Click here to learn more...
Advances in health and medicine.
Marjorie Bekaert Thomas
Publisher/President
Advances in health and medicine.
Advertisement
Diabetes Channel
Reported January 29, 2013

Improving Glucose Levels in Type 1 Diabetes

 

(Ivanhoe Newswire) -- Patients with type 1 diabetes have a hard time controlling their glucose levels because tight glucose control increases the incidence of hypoglycemia.   Insulin pump treatment is available, but hypoglycemia still occurs.  Now, new research shows that a dual-hormone artificial pancreas system improved the control of glucose levels and reduced the risk of hypoglycemia compared with conventional pump treatment.  
 
"Hypoglycemia is feared by most patients and remains the most common adverse effect of insulin therapy,” Ahmad Haidar, Institut de Recherches Cliniques de Montréal and McGill University was quoted as saying.
 
The dual-hormone artificial pancreas delivers insulin and glucagon through infusion pumps based on continuous glucose sensor readings as guided by an intelligent dosing algorithm.  The infusion pumps and glucose sensors are already on the market; however, the intelligent algorithm is new.
 
The trial investigated 15 patients with type 1 diabetes who have been using an insulin pump for at least 3 months.  They were admitted for two 15 hour experiments, where their glucose levels were controlled in one visit using the artificial pancreas system and the other with the conventional pump treatment.  Each visit the patients exercised on a stationary bike, ate an evening meal and bedtime snack, and stayed in the facility until the next morning. 
 
"The dual-hormone artificial pancreas improved glucose control and reduced the risk of hypoglycemia in our 15 participants, as compared with continuous subcutaneous insulin infusion.  Rates of hypoglycemia were reduced, with no increased risk of hyperglycemia,” study authors were quoted as saying.  
 
With the artificial pancreas system, patients’ glucose levels were in the target zone 71% of the time as compared to 57% with the conventional pump treatment.  Also the new treatment resulted in a 20-fold reduction in the number of night-time glucose measurements in the low glucose level range.
 
"Closed-loop delivery systems have the potential to substantially improve the management of diabetes and the safety of patients. These systems will probably be introduced gradually to clinical practice, with early generations focusing on overnight glucose control and using insulin alone," study authors explained.
 
"Although this study is neither the first nor the longest investigation using a dual-hormone artificial pancreas, it is the first to compare such an apparatus to conventional intensive therapy in a randomized design. Treatment with the artificial pancreas increased the amount of time patients spent in the target range of blood glucose levels and decreased hypoglycemia. Thus, Haidar and colleagues show that low doses of glucagon administered under the control of a computer algorithm can act as a counter-regulatory hormone, preventing glucose levels from falling too low,” Drs. David Nathan and Steven Russell at Massachusetts General Hospital, Harvard Medical School, was quoted as saying.
 
SOURCE:  Canadian Medical Association Journal, January 2013
 

 

Related Articles in Latest Medical News:

[ Back to Diabetes Channel Home ]

MEDICAL ALERT!
Stay up to date on Diabetes. We can notify you every time there is a medical breakthrough. Click here to sign up.
EDITOR'S CHOICE
Advertisement

Follow Us On:

Click here to go to Ivanhoe's Twitter page Click here to go to Ivanhoe's Facebook page Click here to go to Ivanhoe's YouTube page

Home | What's New | News Flash | Search/Latest Medical News | E-Mail Medical Alerts!
Ivanhoe FAQ | Privacy Policy | Our TV Partners | Awards | Useful Links | Play It Again, Please
RSS Feeds | Advertising/Sponsorships | Content Syndication | Reprints

Advances in health and medicine.
webdoctor@ivanhoe.com
Copyright © 2014 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802

Premium Content in Latest Medical News Denotes Premium Content in Latest Medical News